Zacks Research Has Optimistic Outlook of SBC Q2 Earnings

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) – Equities research analysts at Zacks Research upped their Q2 2026 earnings per share (EPS) estimates for shares of SBC Medical Group in a report released on Tuesday, May 19th. Zacks Research analyst M. Marin now expects that the company will post earnings of $0.13 per share for the quarter, up from their prior forecast of $0.12. The consensus estimate for SBC Medical Group’s current full-year earnings is $0.45 per share.

Several other equities research analysts have also weighed in on the company. Weiss Ratings raised SBC Medical Group from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, May 8th. Wall Street Zen raised SBC Medical Group to a “hold” rating in a report on Saturday, May 9th. Finally, BTIG Research initiated coverage on SBC Medical Group in a report on Friday, March 6th. They issued a “buy” rating and a $8.00 price objective for the company. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, SBC Medical Group presently has a consensus rating of “Moderate Buy” and a consensus price target of $8.50.

SBC Medical Group Trading Up 11.8%

NASDAQ SBC opened at $3.23 on Thursday. The stock has a market capitalization of $331.32 million, a price-to-earnings ratio of 8.28 and a beta of 0.61. SBC Medical Group has a one year low of $2.78 and a one year high of $5.75. The company has a debt-to-equity ratio of 0.12, a current ratio of 3.82 and a quick ratio of 3.78. The business’s fifty day moving average is $3.71 and its 200-day moving average is $3.92.

SBC Medical Group (NASDAQ:SBC) last released its earnings results on Thursday, May 14th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. The company had revenue of $43.06 million for the quarter, compared to analysts’ expectations of $41.66 million. SBC Medical Group had a return on equity of 15.90% and a net margin of 24.09%.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Geode Capital Management LLC grew its holdings in SBC Medical Group by 37.6% during the 4th quarter. Geode Capital Management LLC now owns 262,043 shares of the company’s stock valued at $1,129,000 after buying an additional 71,664 shares in the last quarter. Millennium Management LLC purchased a new position in SBC Medical Group during the 3rd quarter valued at about $219,000. Charles Schwab Investment Management Inc. grew its holdings in SBC Medical Group by 91.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 27,341 shares of the company’s stock valued at $118,000 after buying an additional 13,074 shares in the last quarter. New York State Common Retirement Fund purchased a new position in SBC Medical Group during the 2nd quarter valued at about $104,000. Finally, Barclays PLC grew its holdings in SBC Medical Group by 123.7% during the 4th quarter. Barclays PLC now owns 17,779 shares of the company’s stock valued at $77,000 after buying an additional 9,831 shares in the last quarter. Hedge funds and other institutional investors own 60.82% of the company’s stock.

Insiders Place Their Bets

In related news, CEO Yoshiyuki Aikawa sold 465,000 shares of SBC Medical Group stock in a transaction dated Tuesday, April 28th. The stock was sold at an average price of $3.02, for a total value of $1,404,300.00. Following the completion of the sale, the chief executive officer owned 78,839,460 shares of the company’s stock, valued at approximately $238,095,169.20. This trade represents a 0.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Over the last ninety days, insiders sold 7,987,900 shares of company stock valued at $20,142,848. Company insiders own 89.47% of the company’s stock.

SBC Medical Group Company Profile

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.